ReDS-guided fluid removal for heart failure patients
Part of Heart & circulation clinical trials.
This trial tests if using a wearable monitor (ReDS) to guide fluid removal helps people hospitalized for heart failure. The goal is to find the right amount of fluid to remove so patients feel better and stay out of the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently in the hospital because of heart failure symptoms like swelling or trouble breathing.
- A blood test on admission showed a high level of NT-proBNP (over 1000 pg/L) or BNP (over 300 pg/L).
- You are between 150 cm and 190 cm tall, and your body mass index (BMI) is between 22 and 39.
- You are not on strong heart medications like inotropes or vasopressors, and you do not have a mechanical heart pump or a heart transplant.
- You do not have a pacemaker or other device in the right lung area, and you are not scheduled for heart surgery or a planned procedure like TAVR or stent placement during this trial.
- Your kidney function is good (GFR at least 20) and you are not on dialysis, and you do not have another serious illness that limits your life to less than a year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people hospitalized with heart failure and signs of fluid overload, such as swelling or fluid in the lungs. It aims to check if patients still have extra fluid when they go home, which may help improve their recovery.
This study uses a noninvasive device (ReDS) to estimate fluid buildup in people hospitalized with acute heart failure. It may help doctors monitor fluid status and guide care more accurately during a hospital stay.
This trial tests a new, non-invasive vest-like device (ReDS) that measures fluid in the lungs of people who had a heart attack and then developed heart failure symptoms after their procedure. It helps doctors monitor fluid levels to improve recovery and outcomes.
This study tests a wearable vest that measures fluid in your lungs without needles. It helps doctors adjust your IV diuretics (water pills) during a hospital stay for heart failure, aiming for more personalized treatment and faster recovery.
This trial tests a new device that measures fluid in your lungs without needles or surgery. It may help your doctor manage heart failure better, especially if you've been in the hospital recently or have symptoms like shortness of breath.
This study tests a wearable vest that measures fluid in your lungs to help doctors adjust water-pill treatments for heart failure. It aims to reduce hospital stay and improve recovery.
Hear when a new Heart Failure (for Example, Fluid Overload) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.